Brokerages expect CME Group Inc (NASDAQ:CME) to announce $965.55 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for CME Group’s earnings. The highest sales estimate is $968.00 million and the lowest is $961.65 million. CME Group posted sales of $929.30 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 3.9%. The business is expected to announce its next quarterly earnings results on Thursday, April 26th.
According to Zacks, analysts expect that CME Group will report full year sales of $965.55 million for the current fiscal year, with estimates ranging from $3.86 billion to $4.07 billion. For the next fiscal year, analysts forecast that the business will report sales of $4.14 billion per share, with estimates ranging from $4.03 billion to $4.23 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover CME Group.
CME Group (NASDAQ:CME) last released its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million for the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period last year, the firm posted $1.14 earnings per share.
A number of brokerages recently commented on CME. ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Bank of America boosted their price objective on shares of CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a research report on Thursday, March 8th. Barclays boosted their price objective on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Finally, Sandler O’Neill reaffirmed a “buy” rating and set a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. CME Group has an average rating of “Buy” and an average price target of $157.77.
In other CME Group news, insider Hilda Harris Piell sold 3,299 shares of CME Group stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total value of $539,452.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total transaction of $31,982.00. Following the completion of the sale, the director now owns 3,809 shares of the company’s stock, valued at $609,097.19. The disclosure for this sale can be found here. Insiders sold 43,024 shares of company stock valued at $6,620,113 over the last quarter. Corporate insiders own 0.57% of the company’s stock.
Institutional investors have recently modified their holdings of the company. ARK Investment Management LLC acquired a new stake in shares of CME Group in the fourth quarter worth $120,000. Valeo Financial Advisors LLC acquired a new stake in shares of CME Group in the third quarter worth $124,000. AlphaOne Investment Services LLC acquired a new stake in shares of CME Group in the fourth quarter worth $146,000. Mosaic Family Wealth LLC acquired a new stake in shares of CME Group in the fourth quarter worth $146,000. Finally, Truewealth LLC acquired a new stake in shares of CME Group in the fourth quarter worth $157,000. Institutional investors and hedge funds own 83.13% of the company’s stock.
Shares of CME Group (NASDAQ:CME) traded down $1.86 on Friday, reaching $162.95. 2,235,010 shares of the company were exchanged, compared to its average volume of 1,647,357. CME Group has a 52-week low of $114.82 and a 52-week high of $171.71. The stock has a market capitalization of $57,586.33, a P/E ratio of 13.81, a PEG ratio of 2.49 and a beta of 0.54. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be paid a $0.70 dividend. The ex-dividend date is Thursday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 dividend on an annualized basis and a yield of 1.72%. CME Group’s payout ratio is 23.45%.
TRADEMARK VIOLATION WARNING: This piece was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://ledgergazette.com/2018/03/14/965-55-million-in-sales-expected-for-cme-group-inc-cme-this-quarter.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.